Le Lézard
Classified in: Health
Subject: SVY

Global Hearing Protection Devices Markets 2016-2024: Overcoming Barriers to Adoption of Noise Control Devices - Key to Demand Growth for Hearing Protection Devices


DUBLIN, November 22, 2017 /PRNewswire/ --

The "Hearing Protection Devices - Global Strategic Business Report" report has been added to Research and Markets' offering.

Research and Markets Logo

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

The US market is further analyzed by the following Segments:

The report profiles 39 companies including many key and niche players such as:

Key Topics Covered:

1. INDUSTRY OVERVIEW

2. COMPETITION

3. MARKET TRENDS

4. KEY GROWTH DRIVERS

5. LEADING REGULATORY BODIES - A BRIEF OVERVIEW

6. PRODUCT OVERVIEW

7. PRODUCT INNOVATIONS/INTRODUCTIONS

8. RECENT INDUSTRY ACTIVITY

9. FOCUS ON SELECT GLOBAL PLAYERS

10. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 39 (including Divisions/Subsidiaries 48)

For more information about this report visit https://www.researchandmarkets.com/research/76r9bf/hearing

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 06:10
Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has been awarded a EUR 1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The 2-year grant...

at 06:08
Aesthetic Management Partners LLC, a manufacturer of skin-based solutions and a provider of energy-based devices announces its collaboration with Croma (Croma-Pharma® GmbH), a global player in the minimally invasive aesthetics market and a leading...

at 06:05
The 2023 U.S. soybean field trials conducted by Texas Crop Science (TCS) demonstrated an average yield increase of 21% in soybean lines incorporating the TCS yield trait. This breakthrough in performance would generate approximately $121 per acre in...

at 06:05
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...

at 06:05
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...

at 06:00
Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced the appointment of Dr. Neil Gallagher to...



News published on and distributed by: